Back
  1. Home
  2. Profile of Françoise Luyckx (ULiège)
Profil

Luyckx Françoise

Département de pharmacie > Chimie médicale

See author's contact details
Main Referenced Co-authors
Scheen, André  (32)
Lefèbvre, Pierre  (14)
Beckers, Albert  (7)
Desaive, Claude  (6)
Gielen, Jean-Louis  (6)
Main Referenced Keywords
Humans (31); Female (15); Male (11); Adult (10); Risk Factors (7);
Main Referenced Unit & Research Centers
Center for Education and Research on Macromolecules (CERM) (1)
Main Referenced Disciplines
Endocrinology, metabolism & nutrition (38)
Surgery (5)
Laboratory medicine & medical technology (4)
General & internal medicine (3)
Public health, health care sciences & services (3)

Publications (total 49)

The most downloaded
44530 downloads
Scheen, A., & Luyckx, F. (2010). L’hyperglycémie provoquée par voie orale (HGPO) revisitée 1re partie : Tolérance au glucose, diabète gestationnel et hypoglycémie réactive. Médecine des Maladies Métaboliques, 4 (5), 569-574. doi:10.1016/S1957-2557(10)70124-3 https://hdl.handle.net/2268/79389

The most cited

422 citations (Scopus®)

Luyckx, F., Desaive, C., Thiry, A., Dewe, W., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1998). Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. International Journal of Obesity, 22 (3), 222-6. doi:10.1038/sj.ijo.0800571 https://hdl.handle.net/2268/12957

Scheen, A., Luyckx, F., Esser, N., & Paquot, N. (March 2024). Vignette diagnostique de l’étudiant. Ne pas négliger le syndrome métabolique. Revue Médicale de Liège, 79 (3), 191 - 194.
Editorial Reviewed verified by ORBi

Gadisseur, R., & Luyckx, F. (29 November 2023). CHU Liège: Impacting CKD patients by leveraging a Clinical Decision Support system [Paper presentation]. IFCC EUROMEDLAB 2021, munich, Germany.

SCHEEN, A., LUYCKX, F., Esser, N., LAMPROYE, A., DELWAIDE, J., & PAQUOT, N. (May 2022). Stéatohépatite non alcoolique (NASH) : un modèle d’inflammation métabolique («métaflammation»). Revue Médicale de Liège, 77 (5-6), 316-322.
Editorial Reviewed verified by ORBi

LADANG, A., VRANKEN, L., LUYCKX, F., LEBRETHON, M.-C., & CAVALIER, E. (2017). Etude rétrospective du bilan thyroïdien: définition de valeurs de référence pédiatriques. Revue Médicale de Liège.
Peer reviewed

Gonzalez Aguilera, B., Syrios, P., GADISSEUR, R., LUYCKX, F., Cavalier, E., Beckers, A., & VALDES SOCIN, H. G. (2016). Persistent low levels of serum hCG due to heterophilic mouse antibodies: an unrecognized pitfall in the diagnosis of trophoblastic disease. Gynecological Endocrinology, 1-3. doi:10.3109/09513590.2015.1132303
Peer Reviewed verified by ORBi

Maiga, I., BETEA, D., Geenen, V., LUYCKX, F., Beckers, A., & VALDES SOCIN, H. G. (2015). Switch from Hashimoto Thyroiditis (HT) to Graves Basedow (GB) disease : a controlled study in a series of 15 patients. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine.

LUYCKX, F., Texeira, J., VALDES SOCIN, H. G., Beckers, A., & Cavalier, E. (2014). Hypervitaminémie B12 : un piège diagnostique pour le biologiste et pour le clinicien ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Française d'Endocrinologie, Lyon 5-8 novembre 2014.

VALDES SOCIN, H. G., SYRIOS, P., GADISSEUR, R., TEIXEIRA, J., LUYCKX, F., BECKERS, A., & CAVALIER, E. (November 2013). Persistent low levels of serum hCG: please do not miss phantom hCG! (pseudohypergonadotropinemia syndrome). Acta Clinica Belgica, 68 (6), 465.
Peer Reviewed verified by ORBi

DE FLINES, J., RORIVE, M., Esser, N., Paquot, N., Luyckx, F., & SCHEEN, A. (2013). La vignette diagnostique de l'etudiant. Mise au point d'un patient consultant pour obesite. Revue Médicale de Liège, 68 (3), 148-53.
Peer reviewed

SCHEEN, A., & LUYCKX, F. (2010). L’hyperglycémie provoquée par voie orale (HGPO) revisitée 2e partie : Indices d’insulinosécrétion, d’insulinosensibilité et de disposition orale. Médecine des Maladies Métaboliques, 4 (6), 684-690.
Peer Reviewed verified by ORBi

Scheen, A., & Luyckx, F. (2010). L’hyperglycémie provoquée par voie orale (HGPO) revisitée 1re partie : Tolérance au glucose, diabète gestationnel et hypoglycémie réactive. Médecine des Maladies Métaboliques, 4 (5), 569-574. doi:10.1016/S1957-2557(10)70124-3
Peer Reviewed verified by ORBi

Tancredi, A., Legros, J.-J., Pire, G., Maassen, P., Luyckx, F., & Reginster, J.-Y. (September 2007). Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire. Aging Male, 10 (3), 159-164. doi:10.1080/13685530701433121
Peer Reviewed verified by ORBi

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x
Peer Reviewed verified by ORBi

Scheen, A., Luyckx, F., & Lefebvre, P. (2006). Comment j'explore...le syndrome metabolique par sa nouvelle definition dite de "consensus". Revue Médicale de Liège, 61 (1), 48-52.
Peer reviewed

Tancredi, A., Reginster, J.-Y., Luyckx, F., & Legros, J.-J. (August 2005). No major month to month variation in free testosterone levels in aging mates. Minor impact on the biological diagnosis of 'andropause'. Psychoneuroendocrinology, 30 (7), 638-646. doi:10.1016/j.psyneuen.2005.02.002
Peer Reviewed verified by ORBi

Tancredi, A., Legros, J.-J., Pire, G., Maassen, P., LUYCKX, F., & Reginster, J.-Y. (March 2005). Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire. Osteoporosis International, 16 (Suppl.3), 39.
Peer Reviewed verified by ORBi

Tancredi, A., Reginster, J.-Y., LUYCKX, F., & LEGROS, J.-J. (March 2005). No major month to month variations in free testosterone levels in aging males. Minor impact on the biological diagnosis of "andropause". Osteoporosis International, 16 (Suppl.3), 107.
Peer Reviewed verified by ORBi

Tancredi, A., Reginster, J.-Y., LUYCKX, F., & LEGROS, J.-J. (March 2005). Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Osteoporosis International, 16 (Suppl.3), 107.
Peer Reviewed verified by ORBi

Scheen, A., Letiexhe, M., Rorive, M., De Flines, J., Luyckx, F., & Desaive, C. (2005). L'etude clinique du mois. Chirurgie bariatrique: les resultats a 10 ans de la Swedish Obese Subjects Study".". Revue Médicale de Liège, 60 (2), 121-5.
Peer reviewed

Tancredi, A., Reginster, J.-Y., Schleich, F., Pire, G., Maassen, P., Luyckx, F., & Legros, J.-J. (September 2004). Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. European Journal of Endocrinology, 151 (3), 355-360. doi:10.1530/eje.0.1510355
Peer Reviewed verified by ORBi

Blacher, S., Maquet, V., Luyckx, F., Martin, D., Schoenen, J., Moonen, G., Jérôme, R., & Pirard, J.-P. (March 2003). Image analysis of the axonal ingrowth into poly(D,L-lactide) porous scaffolds in relation to the 3-D porous structure. Biomaterials, 24 (6), 1033-1040. doi:10.1016/S0142-9612(02)00423-4
Peer Reviewed verified by ORBi

Scheen, A., & Luyckx, F. (2003). Le syndrome metabolique: definitions et donnees epidemiologiques. Revue Médicale de Liège, 58 (7-8), 479-84.
Peer reviewed

Scheen, A., & Luyckx, F. (2003). Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists. Acta Clinica Belgica, 58 (2), 81-91.
Peer Reviewed verified by ORBi

Luyckx, F., & Scheen, A. (2003). Comment j'explore ... la controverse a propos de la place de l'hyperglycemie provoquee par voie orale en clinique. Revue Médicale de Liège, 58 (11), 701-5.
Peer reviewed

Scheen, A., & Luyckx, F. (2002). Obesity and liver disease. Best Practice and Research. Clinical Endocrinology and Metabolism, 16 (4), 703-16. doi:10.1053/beem.2002.0225
Peer Reviewed verified by ORBi

Scheen, A., Philips, J.-C., Luyckx, F., Paquot, N., & Jandrain, B. (2001). Comment j'explore ... les differentes formes de diabete sucre: diagnostic differentiel clinique et biologique. Revue Médicale de Liège, 56 (9), 650-5.
Peer reviewed

Valdes Socin, H. G., Dechenne, C., Luyckx, F., Collette, J., & Beckers, A. (2000). Recherche de macroprolactine chez des patients en dialyse péritonéale. In XVIIIème Congrès de la Société Française d'Endocrinologie - Abstract book.

Valdes Socin, H. G., MAGIS, D., Luyckx, F., Collette, J., & Beckers, A. (2000). Recherche de macroprolactinémie chez des patients avec hyperprolactinémie. In XVIIIème Congrès de la Société Française d'Endocrinologie - Abstract book.

Luyckx, F., & Scheen, A. (2000). Comment j'explore ... les anomalies du metabolisme glucidique, de l'insulinosecretion et de la sensibilite a l'insuline avec une hyperglycemie provoquee par voie orale. Revue Médicale de Liège, 55 (9), 881-5.
Peer reviewed

Luyckx, F., & Scheen, A. (2000). Recommandations pour le traitement de l'obesite. Revue Médicale de Liège, 55 (5), 367-71.
Peer reviewed

Luyckx, F., Delcourt, S., Philips, J.-C., & Scheen, A. (2000). Le dosage des auto-anticorps anti-GAD et anti-IA 2: une aide au diagnostic precoce du diabete de type 1. Revue Médicale de Liège, 55 (3), 169-75.
Peer reviewed

Luyckx, F., Lefebvre, P., & Scheen, A. (2000). Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes and Metabolism, 26 (2), 98-106.
Peer Reviewed verified by ORBi

Lebrun, Y., Luyckx, F., Brue, T., Stevenaert, A., & Beckers, A. (September 1999). Une étiologie immunologique à l'hyperprolactinemie: la macroprolactinémie. Revue Médicale de Liège, 54 (9), 759-63.
Peer reviewed

Luyckx, F., Scheen, A., Desaive, C., Thiry, A., & Lefebvre, P. (1999). Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity. Journal of Clinical Endocrinology and Metabolism, 84 (11), 4293. doi:10.1210/jcem.84.11.6171-4
Peer Reviewed verified by ORBi

Luyckx, F., Scheen, A., & Lefebvre, P. (1999). L'obesite feminine: souci esthetique ou probleme medical? Revue Médicale de Liège, 54 (4), 262-7.
Peer reviewed

Scheen, A., Luyckx, F., Desaive, C., & Lefebvre, P. (1999). Severe/extreme obesity: a medical disease requiring a surgical treatment? Acta Clinica Belgica, 54 (3), 154-61. doi:10.1080/17843286.1999.11754222
Peer Reviewed verified by ORBi

Scheen, A., & Luyckx, F. (1999). Comment j'explore ... un sujet avec un exces ponderal ou une obesite. Revue Médicale de Liège, 54 (6), 553-6.
Peer reviewed

Deschampheleire, M., Luyckx, F., & Scheen, A. (1999). Dysthyroidies et dyslipidemies. Revue Médicale de Liège, 54 (9), 746-50.
Peer reviewed

Luyckx, F., Scheen, A., Letiexhe, M., Desaive, C., Gielen, J.-L., & Lefebvre, P. (1999). Comment je traite ... une obesite severe et ses anomalies metaboliques par une gastroplastie. Revue Médicale de Liège, 54 (3), 138-42.
Peer reviewed

Scheen, A., & Luyckx, F. (1999). Medical aspects of obesity. Acta Chirurgica Belgica, 99 (3), 135-9.
Peer Reviewed verified by ORBi

Luyckx, F., Scheen, A., & Lefebvre, P. (1999). Non-alcoholic steatohepatitis. The Lancet, 354 (9186), 1298-9. doi:10.1016/S0140-6736(05)76068-2
Peer Reviewed verified by ORBi

Luyckx, F., Scheen, A., Proenza, A. M., Strosberg, A. D., Lefebvre, P., & Gielen, J.-L. (1998). Influence of the A-->G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects. International Journal of Obesity, 22 (12), 1244-5. doi:10.1038/sj.ijo.0800775
Peer Reviewed verified by ORBi

Luyckx, F., Desaive, C., Thiry, A., Dewe, W., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1998). Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. International Journal of Obesity, 22 (3), 222-6. doi:10.1038/sj.ijo.0800571
Peer Reviewed verified by ORBi

Scheen, A., Triches, K., Luyckx, F., Letiexhe, M., & Lefebvre, P. (1998). Pharma clinics. Comment je traite ... un patient diabetique avec obesite severe. Revue Médicale de Liège, 53 (7), 386-9.
Peer reviewed

Scheen, A., Paquot, N., Triches, K., Luyckx, F., Letiexhe, M., & Lefebvre, P. (1998). Traitement ultime du diabete de type 2: insulinotherapie intensive ou chirurgie bariatrique? Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 81-97.
Peer Reviewed verified by ORBi

Luyckx, F., Scheen, A., Desaive, C., Dewe, W., Gielen, J.-L., & Lefebvre, P. (1998). Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes and Metabolism, 24 (4), 355-61.
Peer Reviewed verified by ORBi

Luyckx, F., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1997). Le recepteur beta 3-adrenergique: un role dans la predisposition genetique a l'obesite et au diabete? Revue Médicale de Liège, 52 (11), 703-8.
Peer reviewed

Luyckx, F., & Scheen, A. (1997). Pharma-clinics. Le medicament du mois. Le Legalon (silymarine). Revue Médicale de Liège, 52 (12), 792-6.
Peer reviewed

Luyckx, F., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1997). Comment j'explore ... le syndrome d'insulinoresistance grace a ses marqueurs biologiques. Revue Médicale de Liège, 52 (10), 686-91.
Peer reviewed

Contact ORBi